Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Squamous Cell Carcinoma of Head and Neck 173Head and Neck Neoplasms 140Thyroid Neoplasms 59Carcinoma, Non-Small-Cell Lung 58Oropharyngeal Neoplasms 48Melanoma 47Nasopharyngeal Carcinoma 45Colorectal Neoplasms 33Mouth Neoplasms 30Carcinoma, Renal Cell 29Breast Neoplasms 27Uterine Cervical Neoplasms 26Neoplasms 26Ovarian Neoplasms 25Stomach Neoplasms 24Carcinoma, Squamous Cell 23Lung Neoplasms 22Esophageal Neoplasms 22Triple Negative Breast Neoplasms 20Neoplasm Metastasis 20Endometrial Neoplasms 20Salivary Gland Neoplasms 19Thyroid Cancer, Papillary 16Pancreatic Neoplasms 16Sarcoma 15Laryngeal Neoplasms 15Urinary Bladder Neoplasms 13Prostatic Neoplasms 13Colonic Neoplasms 13Carcinoma, Transitional Cell 13

Interventions

Thyrotropin Alfa 1Iodine-131 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Low Risk Differentiated Thyroid Cancer × Head & Neck × Clear all
NCT01837745 2023-05-17

ESTIMABL2

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting
776 enrolled
EndocrineHead & Neck

Low Risk Differentiated Thyroid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡